CONMED Corp — Director's Dealing 2019

Dec 6, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-12-05

Reporting Person: KENNEDY JOHN JED (VP GM CET)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-05	Common Stock	M	19520	$51.30	Acquired	24017	Direct
2019-12-05	Common Stock	F	13555	$113.91	Disposed	10462	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-05	Sars (Stock Appreciation Rights)	$51.30	M	19520	Disposed	2025-02-27	Common Stock (19520)	Direct

Footnotes

F1: The stock appreciation rights ("SARs") were granted under the Company's 1999 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts (20%) over a five year period.